🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,40 USD

Máx. histórico

119,27

4268 días

Caída desde máximo

-69,48%

Rango 52 semanas

18,80 – 36,67

Variación hoy

+0,03%

Cierre anterior

36,39

Rango de hoy

36,38 – 36,41

Volumen hoy

810.925

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,37%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
104,00 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 22 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/03/2011 7,03 7,10 6,96 7,05 +2,92% 1,99% 17.500
16/03/2011 6,93 7,05 6,70 6,85 +0,15% 5,05% 39.200
15/03/2011 6,94 6,95 6,75 6,84 -0,44% 2,88% 9.800
14/03/2011 7,08 7,09 6,83 6,87 -0,15% 3,67% 10.500
11/03/2011 6,90 6,90 6,83 6,88 +1,18% 1,01% 1.000
10/03/2011 6,90 6,91 6,80 6,80 -0,15% 1,59% 1.700
09/03/2011 6,91 7,10 6,79 6,81 -1,30% 4,49% 10.500
08/03/2011 6,91 7,03 6,79 6,90 -0,14% 3,47% 9.400
07/03/2011 6,80 7,09 6,80 6,91 -0,29% 4,26% 7.100
04/03/2011 7,05 7,07 6,84 6,93 -1,70% 3,26% 3.600
03/03/2011 7,02 7,05 6,86 7,05 +1,59% 2,71% 9.900
02/03/2011 7,00 7,05 6,71 6,94 +0,14% 4,86% 15.600
01/03/2011 7,09 7,09 6,87 6,93 +0,43% 3,10% 1.100
28/02/2011 7,15 7,15 6,84 6,90 -2,82% 4,34% 9.100
25/02/2011 6,90 7,15 6,89 7,10 +3,05% 3,77% 21.600
24/02/2011 6,73 6,96 6,73 6,89 -0,29% 3,42% 7.800
23/02/2011 6,71 6,96 6,66 6,91 -0,29% 4,47% 16.800
22/02/2011 6,51 6,96 6,51 6,93 +7,44% 6,91% 26.600
18/02/2011 6,93 7,00 6,41 6,45 -7,06% 8,51% 54.200
17/02/2011 6,50 6,99 6,50 6,94 +5,47% 7,54% 13.100
16/02/2011 7,03 7,03 6,16 6,58 -4,78% 12,38% 28.500
15/02/2011 7,00 7,04 6,90 6,91 -1,29% 2,00% 11.900
14/02/2011 6,98 7,00 6,87 7,00 +1,16% 1,86% 12.200
11/02/2011 7,00 7,01 6,76 6,92 +4,06% 3,57% 24.300
10/02/2011 6,68 6,77 6,25 6,65 +6,74% 7,78% 8.200
09/02/2011 6,72 6,79 6,18 6,23 -7,29% 9,08% 13.700
08/02/2011 7,00 7,00 6,57 6,72 -4,55% 6,14% 14.400
07/02/2011 7,00 7,05 7,00 7,04 +0,14% 0,71% 287.800
04/02/2011 7,07 7,07 7,00 7,03 +0,14% 0,99% 141.000
03/02/2011 7,00 7,25 6,95 7,02 — 4,29% 1.710.500